Trial Profile
An Observational Study of Dutasteride and Alpha-Blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Alpha adrenergic receptor antagonists
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 14 May 2011 New trial record